Fortress Biotech, Inc. - Insider Non-Derivative Transactions at Checkpoint Therapeutics, Inc. (CKPT) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 20, 2024, Fortress Biotech, Inc.'s relationship to Checkpoint Therapeutics, Inc. (CKPT) is TenPercentOwner, and currently has 2,096,278 shares of COMMON STOCK, PAR VALUE $0.0001.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CKPT insiders.

Data Source: SEC.
Fortress Biotech, Inc. - Insider Non-Derivative Transactions of CKPT COMMON STOCK, PAR VALUE $0.0001
Fortress Biotech, Inc. - Insider Non-Derivative Transactions at CKPT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 21, 2024 Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) 193905 0 2096278
Dec 30, 2023 Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) 158134 0 1902373
Sep 26, 2023 Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) 80906 0 1744239
Jul 1, 2023 Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) 81406 0 1663333
Apr 5, 2023 Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) 42500 0 1581927
Apr 1, 2023 Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) 35714 0 1539427
Jan 6, 2023 Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) 368907 0 1503713